Three Benesh Friedlander Coplan & Aronoff attorneys say a suit against FDA filed by the Alliance for Natural Health USA could change the way that supplements are marketed.
FDA publishes a guidance notifying blood establishments about agency recommendations for screening and deferring blood donors in response to an Ebola outbreak.
Three Benesh Friedlander Coplan & Aronoff attorneys say a suit against FDA filed by the Alliance for Natural Health USA could change the way that supplements are marketed.
FDA publishes a guidance notifying blood establishments about agency recommendations for screening and deferring blood donors in response to an Ebola outbreak.
FDA warns Excelvision about CGMP violations in the production of drugs at its facility in Annonay, France.
FDA warns Genzyme Ireland about the failure of the firm’s quality control unit to ensure that drugs comply with CGMP requirements.
